RankingsPricing
  1. US-listed companies
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. Financials
  4. Cash from investing

TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA

Market cap
$28.4B
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 2024792-18.18%
Dec 31, 2023968+47.56%
Dec 31, 2022656-56.93%
Dec 31, 20211,523+76.48%
Dec 31, 2020863-36.31%
Dec 31, 20191,355-27.38%
Dec 31, 20181,866-13.77%
Dec 31, 20172,164-106.05%
Dec 31, 2016-35,740+542.23%
Dec 31, 2015-5,565+283.79%
Dec 31, 2014-1,450+26.42%
Dec 31, 2013-1,147+1.15%
Dec 31, 2012-1,134-85.08%
Dec 31, 2011-7,601+39.34%
Dec 31, 2010-5,455

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)